United Arab Emirates Ministry of Health and Prevention Approves Biomericaās FortelĀ® Kidney Test for Home Use
(NASDAQ:BMRA) IRVINE, Calif., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), a global provider of advanced diagnostic solutions, announced today announced that the United Arab...
What are the timelines and regulatory hurdles for further international approvals, and how might those shape the stock's valuation over the next 12ā24 months?
What is the potential market size and growth trajectory for home-use kidney diagnostics in the UAE and broader Middle East region, and how does this position BMRA against competitors like Abbott and Roche?
How will the UAE approval of the FortelĀ® Kidney Test affect Biomerica's revenue forecasts and earnings guidance?
11 days ago